Stage II Bladder Urothelial Carcinoma AJCC v6 and v7

Preferred Label : Stage II Bladder Urothelial Carcinoma AJCC v6 and v7;

NCIt synonyms : Stage II Urinary Bladder Transitional Cell Carcinoma; Stage II Bladder Urothelial Carcinoma AJCC v6; Stage II Transitional Cell Carcinoma of Urinary Bladder; Stage II Transitional Cell Carcinoma of the Urinary Bladder; Stage II Transitional Cell Carcinoma of Bladder; Stage II Transitional Cell Carcinoma of the Bladder; Stage II Bladder Urothelial Carcinoma AJCC v7; Stage II Bladder Transitional Cell Carcinoma; Stage II Bladder Urothelial Carcinoma;

NCIt related terms : Stage II Bladder Urothelial Cancer;

NCIt definition : Stage II includes: (T2a, N0, M0); (T2b, N0, M0). T2a: Tumor invades superficial muscle (inner half). T2b: Tumor invades deep muscle (outer half). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th Eds.);

Neoplastic status : Malignant;

Details

Origin ID

C8939;

UMLS CUI

C0862402;

Currated CISMeF NLP mapping
- Bladder transitional cell carcinoma stage II [MedDRA Preferred Term]
- Transitional cell carcinoma of the bladder stage II [MedDRA LLT]
- Urothelial carcinoma bladder stage II [MedDRA LLT]
Disease excludes abnormal cell
- Malignant Stromal Cell [NCIt concept]
- Neoplastic Smooth Muscle Cell [NCIt concept]
Disease may have findings
- Dysuria [NCIt concept]
- Hematuria [NCIt concept]
- Urinary Frequency [NCIt concept]
Excludes anatomical site(s)
- Urethra [NCIt concept]
Has associated anatomic sites
- Bladder [NCIt concept]
- Genitourinary System [NCIt concept]
- Urinary System [NCIt concept]
- Urinary Tract [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Bladder transitional cell carcinoma stage II [MedDRA Preferred Term]
- Transitional cell carcinoma of the bladder stage II [MedDRA LLT]
- Urothelial carcinoma bladder stage II [MedDRA LLT]
concept_is_in_subset
- CTRP Disease Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
disease_has_abnormal_cell
- Malignant Cell [NCIt concept]
- Malignant Epithelial Cell [NCIt concept]
- Malignant Transitional Cell [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Epithelial Cell [NCIt concept]
- Neoplastic Transitional Cell [NCIt concept]
disease_has_finding
- Carcinomatous Component Present [NCIt concept]
- Epithelial Component Present [NCIt concept]
- Invasive Lesion [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
disease_has_normal_cell_origin
- Bladder Urothelial Cell [NCIt concept]
- Epithelial Cell [NCIt concept]
- Urothelial Cell [NCIt concept]
disease_has_normal_tissue_origin
- Bladder Urothelium [NCIt concept]
- Epithelial Tissue [NCIt concept]
- Urothelium [NCIt concept]
disease_has_primary_anatomic_site
- Bladder [NCIt concept]
- Genitourinary System [NCIt concept]
- Urinary System [NCIt concept]
- Urinary Tract [NCIt concept]
disease_is_stage
- AJCC v6 Stage [NCIt concept]
- AJCC v7 Stage [NCIt concept]
- Stage II [NCIt concept]
disease_may_have_cytogenetic_abnormality
- Gain of Chromosome 17q [NCIt concept]
- Gain of Chromosome 1q [NCIt concept]
- Gain of Chromosome 5p [NCIt concept]
- Gain of Chromosome 8q [NCIt concept]
- Loss of Chromosome 10q [NCIt concept]
- Loss of Chromosome 11p [NCIt concept]
- Loss of Chromosome 18q [NCIt concept]
- Loss of Chromosome 2q [NCIt concept]
- Loss of Chromosome 5q [NCIt concept]
- Loss of Chromosome 8p [NCIt concept]
- Loss of Chromosome 9p [NCIt concept]
- Loss of Chromosome 9q [NCIt concept]
- Loss of Chromosome Y [NCIt concept]
disease_may_have_molecular_abnormality
- ARID1A Gene Mutation [NCIt concept]
- CDKN1A Gene Mutation [NCIt concept]
- CDKN2A Gene Mutation [NCIt concept]
- CREBBP Gene Mutation [NCIt concept]
- EP300 Gene Mutation [NCIt concept]
- ERBB2 Gene Mutation [NCIt concept]
- ERBB3 Gene Mutation [NCIt concept]
- FGFR3 Gene Mutation [NCIt concept]
- HRAS Gene Mutation [NCIt concept]
- KDM6A Gene Mutation [NCIt concept]
- KMT2C Gene Mutation [NCIt concept]
- KMT2D Gene Mutation [NCIt concept]
- KRAS Gene Mutation [NCIt concept]
- MLL Gene Mutation [NCIt concept]
- PIK3CA Gene Mutation [NCIt concept]
- RB1 Gene Mutation [NCIt concept]
- TERT Promoter Mutation [NCIt concept]
- TP53 Gene Mutation [NCIt concept]
- TSC1 Gene Mutation [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients